• Non ci sono risultati.

Scarica il programma

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma"

Copied!
1
0
0

Testo completo

(1)

9 TH INTERNATIONAL CONFERENCE ON THORACIC ONCOLOGY

June 24TH, 2021 THURSDAY

15.00 WELCOME AND INTRODUCTION TO THE CONFERENCE Filippo de Marinis (Milan, IT)

15.10 KEYNOTE LECTURE

BALANCING COSTS AND CLINICAL BENEFITS IN MEDICAL ONCOLOGY

Solange Peters (Lausanne, CH)

SESSION 1

chair: Fortunato Ciardiello (Naples, IT)

15.30 – 15.50 egFr anD aLK

Tony Mok (Hong Kong, HK)

15.50 – 16.10 rOs1 anD BraF

Stephen Liu (Washington, US) 16.10 Discussion

SESSION 2

chair: Nicola Normanno (Naples, IT)

16.40 – 17.00 Met anD Kras

Juergen Wolf (Cologne, DE)

17.00 – 17.20 ret anD ntrK

Alex Drilon (New York, US) 17.20 Discussion

SESSION 3

chair: Cesare Gridelli (Avellino, IT)

17.50 – 18.10 neOaDJUVant targeteD tHeraPies Suresh Ramalingam (Atlanta, US)

18.10 – 18.30 aDJUVant targeteD tHeraPies Roy Herbst (North Haven, US) 18.30 Discussion

Conclusion Day 1

June 25TH, 2021 FRIDAY

SESSION 4

chair: Filippo de Marinis (Milan, IT)

14.30 – 14.50 singLe agent in i anD ii Line Roy Herbst (North Haven, US)

14.50 – 15.10 cOMBO iO+ct (±Beva)

Shirish Gadgeel (Ann Arbor, US)

15.10 – 15.30 cOMBO iO+iO+ct

Martin Reck (Grosshansdorf, DE) 15.30 Discussion

SESSION 5

chair: Marina Garassino(Chicago, US)

16.00 – 16.20 targeting cO-inHiBitOrY/cO-stiMULatOrY signaLs Suresh Ramalingam (Atlanta, US)

16.20 – 16.40 targeting tHe tUMOr MicrOenVirOnMent Fabrice Barlesi (Marseille, FR)

16.40 Discussion

SESSION 6

chair: Lorenzo Spaggiari (Milan, IT)

17.10 – 17.30 neOaDJUVant/aDJUVant treatMent Shirish Gadgeel (Ann Arbor, US)

17.30 – 17.50 LOcOregiOnaL treatMent Luis Paz Ares (Madrid, ES) 17.50 Discussion

SESSION 7

chair: Lucio Crinò (Meldola, IT) 18.10 – 18.30 scLc

Stephen Liu (Washington, US) 18.30 – 18.50 MPM

Paul Baas (Amsterdam, NL) 18.50 Discussion

19.10 thanks and goodbye

Filippo de Marinis (Milan, IT) Conclusion Day 2

PROGRAMME

THE TARGET DAY

METASTATIC DISEASE

EARLY DISEASE

Under the auspices of

scientiFic  secretariat aiOt - associazione italiana di Oncologia toracica

Via salaria, 237 - 00199 roma tel. +(39) 333 65 93 541 - Fax (+39) 06 85 40 679 [email protected] - www.oncologiatoracica.it

Organizing secretariat by sOs s.r.l.

Via salaria, 237 - 00199 roma tel. (+39) 333 65 93 541 - Fax (+39) 06 85 40 679 www.scientificorganizingservice.com - [email protected]

WELCOME FROM THE PRESIDENT

Dear Collegue,

it’s my great pleasure to invite you to partecipate in the proceedings of 9th Italian Conference on Thoracic Oncology (CIOT) that, in its annual recurrence, will take place in Virtual Format from June 24thto June 25th2021 organized by AIOT (Italian Association of Thoracic Oncology) and that I’ve the responsibility to chair.

I would like to call your attention to at least three interesting aspects of Milan’s Conference that make the appointment very peculiar and that I identify in its International form, in the location and in its goals.

International form

The 70% of Faculty is composed of foreign speakers, everybody playing an active part in clinical research in Thoracic Oncology and KOL in their respective countries. We expect significant foreign delegations. The official language of the Conference will be English.

Virtual Format

For the second time, due to the emergency of COVID-19, the 9th International Conference on Thoracic Oncology will take place in virtual format to provide clinicians all over the world with access to the contributions.

Goals

Setted immediately after ASCO, the Conference will give an update on the data coming from Clinical Research in Thoracic Oncology directly from the voice of its Authors more representative in an appointment that we would like to be lasting inside of the international congressional track.

For these reasons I’m trusting that you should appreciate the effort of the organizing secretariat to realize this scientific meeting doing credit to us with your attendance in our website.

Arrivederci

President of 9thCIOT Filippo de Marinis

PRESIDENT OF THE CONFERENCE SCIENTIFIC & ORGANIZING COMMITTEE PRESIDENT OF THE CONFERENCE

Filippo de Marinis

SCIENTIFIC & ORGANIZING COMMITTEE

AIOT BOARD

Fortunato Ciardiello Filippo de Marinis Cesare Gridelli Lucio Crinò

Marina C. Garassino Nicola Normanno Lorenzo Spaggiari Rossella Spinetti

THE IMMUNO DAY

METASTATIC DISEASE

STRATEGIES TO OVERCOME RESISTANCE TO CPIs

EARLY and LOCO-REGIONAL DISEASE

SCLC/MPM

VIRTUAL FORMAT

June 24

TH

- 25

TH

2021

PROGRAMMA DI FORMAZIONE A DISTANZA ACCREDITATO PRESSO LA CNFC 1080-318391 I crediti ECM per questo programma sono rilasciati da SOS Srl Scientific Organizing Service, provider nazionale accreditato standard AGENAS a fornire programmi di formazione continua per gli operatori sanitari. SOS Srl si assume la responsabilità dei contenuti, la qualità e la correttezza etica di questa attività ECM.

FIGURE ACCREDITATE

• Biologo;

• Farmacista nelle discipline di: farmacia ospedaliera, farmacia territoriale;

• Infermiere;

• Medico chirurgo nelle discipline di: anatomia patologica, chirurgia toracica, malattie dell’apparato respiratorio, medicina generale (medici di famiglia), medicina interna, oncologia, radiodiagnostica, radioterapia

N. CREDITI: 13,5 - Durata prevista dell’attività formativa: 9 ore

OBIETTIVO FORMATIVO: 1- Applicazione nella pratica quotidiana dei principi e delle procedure dell'evidence based practice (EBM - EBN - EBP)

1 - REGISTRAZIONE

Accedere all’indirizzo www.scientificorganizingservice.com/fadper registrarsi alla piattaforma, creando il proprio account. Collegarsi con le credenziali personali e usufruire del percorso formativo, iscrivendosi al corso specifico, esclusivamente a partire dalle ore 10.00 del 23 giugno 2021.

2 - QUESTIONARIO DI APPRENDIMENTO

Completato il percorso, sarà necessario compilare il questionario di apprendimento. Tale test può essere ripetuto al massimo 5 volte e viene superato completando correttamente il 75% dei quesiti proposti.

3- CERTIFICATO DI ACQUISIZIONE CREDITI

Superato il test e ottenuto il 90% della presenza totale al corso (unico accreditamento) è possibile visualizzare e scaricare il certificato di attribuzione dei crediti ECM in formato PDF.

HELP DESK attivo dal 23 al 28 giugno 2021

Assistenza Tecnica: Niccolò Semprebene, Tel. (+39) 335 8200986 Maria Vittoria Argenti, Tel. (+39) 333 1499382

Rossella Spinetti, Tel. (+39) 333 6593541

• ISCRIZIONI GRATUITE •

SPONSOR ARGENTO

SPONSOR BRONZO

ALTRI SPONSOR

Si ringrazia inoltre Boehringer-Ingelheim

Novartis Italia

Per cambiare

la medicina, nei fatti

In Novartis, affrontiamo con la forza dell’innovazione scientifica alcune tra le sfide sanitarie più impegnative della società. I nostri ricercatori lavorano per allargare i confini della scienza, ampliare la comprensione delle malattie e sviluppare prodotti innovativi in aree dove ci sono grandi bisogni medici ancora non soddisfatti.

Con passione, siamo impegnati a scoprire nuovi modi per prolungare e migliorare la vita dei pazienti.

Riferimenti

Documenti correlati

Baer MD Professor of Dermatology, Departments of Medicine (Oncology) and Urology, Director Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support,

“IO FORUM 2021 Emerging Approaches for Immunotherapy in Oncology - Regional Webinar PIEMONTE” è il secondo appuntamento della roadmap.. L’evento intende focalizzare e comunicare

Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell

Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell

OC-11 - Risk factors for recurrence in patients with cancer-associated venous thromboembolism: results from the Hokusai-VTE cancer

it is with pleasure that I welcome you to Rome for the 6 th International Meeting on New Drugs and New Insights in Breast Cancer, bringing together clinicians, mainly

Igor Puzanov - Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology,

Igor Puzanov - Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology,